ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,633.09
0.13%
US Tech 100
18,929.60
0.00%
Dow Jones
41,622.08
0.55%
Brent Oil
72.275
-0.47%
Bitcoin
58,780.59
1.02%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Pharvaris NV (PHVS) Quote

Pharvaris NV

Pharvaris NV (PHVS)

NASDAQ
20.60
0.00
(0.00%)
Closed September 17 4:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
20.60
Bid
20.19
Ask
22.50
Volume
-
0.00 Day's Range 0.00
15.00 52 Week Range 33.00
Market Cap
1.077B
Previous Close
20.60
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
74,781
Shares Outstanding
52,290,212
Dividend Yield
-
PE Ratio
-10.68
Earnings Per Share (EPS)
-1.93
Revenue
-
Net Profit
-100.88M

About Pharvaris NV

Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications. Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.pharvaris.com
Headquarters
Leiden, South Holland, Nld
Founded
-
Pharvaris NV is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PHVS. The last closing price for Pharvaris NV was $20.60. Over the last year, Pharvaris NV shares have traded in a share price range of $ 15.00 to $ 33.00.

Pharvaris NV currently has 52,290,212 shares outstanding. The market capitalization of Pharvaris NV is $1.08 billion. Pharvaris NV has a price to earnings ratio (PE ratio) of -10.68.

Ask ADVFN Intelligence (AI)

PHVS Latest News

More News

Form 144 - Report of proposed sale of securities

11 hours ago
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

September 05 2024
Edgar (US Regulatory)

Pharvaris Provides Business Update and Expands Development Program for Deucrictibant

CHAPTER-3, the global pivotal Phase 3 clinical study of deucrictibant for the prophylactic treatment for HAE using once-daily extended-release tablet, is expected to initiate by...

September 05 2024
GlobeNewswire Inc.

Pharvaris Presents Deucrictibant Long-Term Extension Data for Both the Prophylactic and On-Demand Treatment of HAE at the Bradykinin Symposium 2024

Extension data confirm the observed safety and tolerability profile from Phase 2 studies and further support the potential for deucrictibant to become a preferred therapy for the management of...

September 05 2024
GlobeNewswire Inc.

Pharvaris Presents Data at the Bradykinin Symposium 2024

ZUG, Switzerland, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and...

September 05 2024
GlobeNewswire Inc.

Deucrictibant Clinical, Real-World, Nonclinical, and Discovery Data to be Presented at the Bradykinin Symposium

ZUG, Switzerland, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and...

August 28 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

August 14 2024
Edgar (US Regulatory)

Pharvaris Reports Second Quarter 2024 Financial Results and Provides Business Update

Alignment with regulatory agencies following End-of-Phase 2 meetings for the prophylactic development of deucrictibant; global startup activities of CHAPTER-3, pivotal Phase 3 study of...

August 14 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

June 11 2024
Edgar (US Regulatory)

Pharvaris Announces Annual Meeting of Shareholders

ZUG, Switzerland, June 11, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to treat and...

June 11 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.84.040404040419.821.5419.612995620.96184601CS
42.111.351351351418.521.541712669319.07991528CS
122.5714.25402107618.0321.5415.57478118.48757542CS
26-2.68-11.512027491423.2826.56515.377270819.65648149CS
520.552.7431421446420.0533159215923.01618289CS
1562.4413.43612334818.16331.7719812712.82435045CS
260-4.4-17.62542.861.7717466013.71003073CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.1287
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 63.2435
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.88
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 9.75
(0.00%)
0
AACGATA Creativity Global
$ 0.5025
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.1287
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 63.2435
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.88
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 9.75
(0.00%)
0
AACGATA Creativity Global
$ 0.5025
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.1287
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 63.2435
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.88
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 9.75
(0.00%)
0
AACGATA Creativity Global
$ 0.5025
(0.00%)
0

PHVS Discussion

View Posts
Monksdream Monksdream 2 days ago
PHVS trying to break out of the recent channel
👍️0
Monksdream Monksdream 8 months ago
PHVS new 52 week low
👍️0
europtiger europtiger 1 year ago
Haven’t been here in a while… but this one is just a sweet long position. Soon to be 20+ imho
👍️0
subslover subslover 2 years ago
Excellent call on the $12,00's. I just confirmed today's 12,24 is the 52-week high! :)
👍️0
europtiger europtiger 2 years ago
Yeah looking great… my average now ist even 8,30 as I bought 2 more k when she was in the 7,s so I got lucky. Let’s see, hoping for 12 break soon here

Good luck to you
👍️0
subslover subslover 2 years ago
Your doing great closed $11.20 :)
👍️0
europtiger europtiger 2 years ago
So I got now average 8,80$

Let’s see I guess
👍️0
Pt3 Pt3 2 years ago
What going on back to 7
👍️0
winna winna 2 years ago
???
👍️0
MT101 MT101 2 years ago
Ez hold. Down 12% and you think it’s bearish after a 400% run hahahahah loaded more today too.
👍️0
winna winna 2 years ago
You were saying?
👍️0
Invest-in-America Invest-in-America 2 years ago
PHVS: "RED prices at morning, sailors take warning!!" (Well, something like that.)



👍️0
Invest-in-America Invest-in-America 2 years ago
PHVS:: Were you referring to YOURSELF, Sir, with that post????? (See today's PHVS chart, below.)

👍️0
Invest-in-America Invest-in-America 2 years ago
PHVS: Where have all the smart-ass, know-it-all's gone??????? (Can't even discern conspicuous FLUFF PR's when ya see 'em!!!)

👍️0
Invest-in-America Invest-in-America 2 years ago
PHVS: The RED PRICE will edify you today --- so, ignore me if you like. Bottom line, Sir, you need a REMEDIAL course in how IGNORANT this primitive Planet is in the area of Human THERAPEUTIC Medical (so-called) "SCIENCE".
👍️0
MT101 MT101 2 years ago
I actually just loaded every more in PM. This is going to explode at open most likely another 300-400% day. Your screwed dude you should have covered yesterday!
👍️0
Invest-in-America Invest-in-America 2 years ago
It is going NOWHERE, Dude. It had its run; it's DONE Hope you didn't hold any overnight.
👍️0
MT101 MT101 2 years ago
Everything your saying is false. I sure hope your joking about being a short, your going to get toasted to a crisp today if you are.. this things about to go parabolic. Monday will probably blow up too. Easily $40+ here
👍️0
MT101 MT101 2 years ago
Shorts are trapped this is HKD 2.0
👍️0
Invest-in-America Invest-in-America 2 years ago
PHVS: It was a monster runner, that's for sure. GOOD LUCK today, however. (Pure FLUFF news, if there ever was any anywhere.)
👍️0
Invest-in-America Invest-in-America 2 years ago
PHVS: I do NOT own any of this. And, if I ran Wall Street, SHORTING any stock would be prohibited by LAW. WHY?? Because such practice is betting on a Company to LOSE value. Bottom line, SHORTING stocks is yet another example of the CORRUPT nature of American Commerce, Industry, & Government at its CORE. Similar to how in America, just ONE GUY/GAL can win a ONE-BILLION-DOLLAR lottery all for their SELFISH SELVES!!!
👍️0
MT101 MT101 2 years ago
Lol your going to lose your entire portfolio trying to short this one. Please be my guest! Love seeing shorts get their asses burned!
👍️0
MT101 MT101 2 years ago
They will try but the buying pressure is way to aggressive right now and short shares are hard to find, I checked multiple platforms. Shorts that are holding there position overnight are going to get wrecked af tomorrow
👍️0
doebop doebop 2 years ago
Agree best to wait for pop tomorrow then short if you can borrow
👍️0
Laster Laster 2 years ago
Actually Hereditary Angioedema is very hard to treat. Different than ACE induced angioedema. News looks promising but it is phase 2 data. The bigger concern is that the FDA halted their US trials on August for some reason. Therefore, the company is only doing trials outside the US.

Stock dropped $2 after hours. Let’s see how it trades Premarket.

I almost got into this at $4.70 just around noon but the stock immediately exploded to $5.80. Never seen anything like that. I saw that it was a market buy order of about 150,000 shares. Wow.
👍️0
Pt3 Pt3 2 years ago
Short can't short cuz this going to 20-30
👍️0
winna winna 2 years ago
They will short this down tomorrow
👍️0
MT101 MT101 2 years ago
Dude your so screwed if you don’t cover before tomorrow open. It’s going to $20-40
👍️0
Invest-in-America Invest-in-America 2 years ago
Watch out for RED INK tomorrow, behind this FLUFF-NEWS crap!!!
👍️0
Invest-in-America Invest-in-America 2 years ago
PHVS: My post is the TRUTH, Dude; if you can't recognize pure FLUFF Medical "NEWS" --- & about an extremely RARE disease, to boot --- well then, nobody can help you, Sir. (GOOD LUCK!!!)
👍️0
MT101 MT101 2 years ago
False. I recommend you cover your short or get burned out. This is going to $20-40 tomorrow. Tik Tok Tik Tok your running out of time.
👍️0
Invest-in-America Invest-in-America 2 years ago
PHVS: Price SOARED today, & all behind the most FLUFF news of this calendar year so far!! (Maybe of this ENTIRE year, moving forward; a firm that is LOSING money every year, & barely past the "Proof Of Concept" stage for yet ANOTHER purported treatment for whatever.)
👍️0
MT101 MT101 2 years ago
That’s good. I loaded 3k shares here around $10 range. I think this is going to $20-40 possibly. Massive news
👍️0
europtiger europtiger 2 years ago
Got me 2,5 k shares just now below 10$

Could see a nice buy out offer at some stage
👍️0
MT101 MT101 2 years ago
Going to $20-30 range
👍️0
subslover subslover 2 years ago
This stock has sure gone crazy! LMAO all the way to Wells Fargo!
👍️0
Invest-in-America Invest-in-America 2 years ago
PHVS: Indeed!!! NOT even that, per se --- really just "Proof of Concept"!! What a JOKE!! Hey, Dude, Wall Street is a GAMBLING CASINO. ANY stupid stock can SOAR; if some TRENDING/INFLUENTIAL folks or entities are pumping it, that is.

This little PUMPED PUPPY might just Close today at circa 900% UP!!!
👍️0
subslover subslover 2 years ago
HALTED for the 3rd time at 1;30 PM @ $11.93
👍️0
subslover subslover 2 years ago
$10.00 just breached.
👍️0
winna winna 2 years ago
They will short this big time
👍️0
Cosa Cosa 2 years ago
This big move is from phase 2 results?
👍️0
subslover subslover 2 years ago
Trading resumed at 12:30 pm @ $7.50. What a wild ride this turned out to be!
👍️0
davidsson10 davidsson10 2 years ago
Yes, that'll work.....
👍️0
subslover subslover 2 years ago
HALTED again 12;28pm @ $8.18
👍️0
subslover subslover 2 years ago
Trading resumed at 12:17pm @ $7.00
👍️0
subslover subslover 2 years ago
HALTED at noon @ $5.78
👍️0
subslover subslover 2 years ago
Pharvaris Reports Third Quarter 2022 Financial Results and Provides Business Update


https://www.otcmarkets.com/stock/PHVS/news/story?e&id=2400295
👍️0
subslover subslover 2 years ago
Pharvaris Announces Positive Top-line Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks
https://www.otcmarkets.com/stock/PHVS/news/story?e&id=2400291
👍️0

Your Recent History

NASDAQ
PHVS
Pharvaris NV
NASDAQ
POAI
Predictive Oncology
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved